- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Magdeburg, Otto-von-Guericke-Universität Magdeburg, Dissertation, 2020
- Schlagwort
-
Acute leukemia
Volterra
- Ereignis
-
Veröffentlichung
- (wo)
-
Magdeburg
- (wer)
-
Universitätsbibliothek Otto-von-Guericke-Universität
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.25673/35478
- URN
-
urn:nbn:de:gbv:ma9:1-1981185920-356876
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jost, Felix
- Sager, Sebastian
- Universitätsbibliothek Otto-von-Guericke-Universität
Entstanden
- 2020
Ähnliche Objekte (12)
Pathophysiology and treatment of NUP98-NSD1 acute myeloid leukemia
Acute lymphoblastic leukemia
Pediatric Acute Myeloid Leukemia: Risk Group Characterization and Salvage Treatment
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
New findings on Aclarubicin in the treatment of acute myeloid leukemia
In silico optimisation of cancer treatment schedules
In silico optimisation of cancer treatment schedules
Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
FLT3 specific antibody-drug-conjugate for the treatment of acute myeloid leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia
Pathophysiology and treatment of NUP98-NSD1 acute myeloid leukemia
Acute lymphoblastic leukemia
Pediatric Acute Myeloid Leukemia: Risk Group Characterization and Salvage Treatment
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
New findings on Aclarubicin in the treatment of acute myeloid leukemia
In silico optimisation of cancer treatment schedules
In silico optimisation of cancer treatment schedules
Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
FLT3 specific antibody-drug-conjugate for the treatment of acute myeloid leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia
Pathophysiology and treatment of NUP98-NSD1 acute myeloid leukemia
Acute lymphoblastic leukemia
Pediatric Acute Myeloid Leukemia: Risk Group Characterization and Salvage Treatment
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
New findings on Aclarubicin in the treatment of acute myeloid leukemia
In silico optimisation of cancer treatment schedules
In silico optimisation of cancer treatment schedules
Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
FLT3 specific antibody-drug-conjugate for the treatment of acute myeloid leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia